Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Wesfarmers (ASX:WES) share price on watch with API update

The Wesfarmers Ltd (ASX: WES) share price is in focus as it announced another update regarding the Australian Pharmaceutical Industries Ltd (ASX: API) bid.

Wesfarmers still interested in API

The diversified business noted the non-binding indicative proposal made by Woolworths Group Ltd (ASX: WOW) to acquire API. That bid was $1.75 per API share, a premium of $0.20 per share, or 12.9% in percentage terms compared to the Wesfarmers bid.

However, Wesfarmers said that it continues to believe its proposal to acquire API remains in the best interests of API shareholders and stakeholders, and that it will significantly benefit community pharmacists and Priceline franchisees.

Why not match the bid?

There seems to be two reasons that Wesfarmers hasn’t jumped to increase its bid.

The first is that Wesfarmers has the right to match any proposal in the event that it becomes capable of acceptance is considered superior by the API board. Woolworths’ bid seemingly can’t yet be accepted by API.

Wesfarmers also seems to be putting a lot of focus on the fact that it would be better for independent pharmacies and Priceline franchisees. It has been meeting and listening to representatives from across the sector.

The company said that it supports the community pharmacy model which allows pharmacists to meet the health and wellbeing needs of their patients and customers. It’s committed to support pharmacist owners, many being small businesses, to grow their pharmacies over time. That includes growth in prescription medicines, along with growth in services and broader non-prescription health, personal care and beauty products.

Wesfarmers also noted that key API stakeholders, including community pharmacists and Priceline franchisees, have expressed concern about Sister Club customer data being shared with loyalty programs where there is significant overlap with product ranges sold in pharmacies and supermarkets which compete.

I think this is a positive for the Wesfarmers share price – paying less for API would be a positive.

What about Flybuys?

Coles Group Ltd (ASX: COL) was divested from Wesfarmers Ltd (ASX: WES), though Wesfarmers still owns a 50% holding of Flybuys. Wesfarmers has undertaken to keep all of API customer data separate from Coles.

Wesfarmers said this assurance provides API and its community pharmacists, including current and future Priceline franchisees, with comfort that their customer data will be protected from supermarket competitors.

The company said that it will utilise its e-commerce, data and digital capabilities to enhance the API online offer and drive customer engagement, including foot traffic and in-store sales for community pharmacists.

Final thoughts on Wesfarmers and the share price

This seems like a smart, considered decision by Wesfarmers. It doesn’t need to rush into upping the bid if it doesn’t need to. It has a sizeable voting position, owning 19.3% of the business already, which it could use to vote against a Woolworths bid.

If pharmacists and franchisees don’t want Woolworths to take over, then Wesfarmers could still be in the driving seat.

Wesfarmers is a great business and I’d be happy to have it in my portfolio, though I’d hope for better value before buying – I’m not sure if these booming sales will continue in FY23 and onwards.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content